$5.39 Billion is the total value of BAIN CAPITAL INVESTORS LLC's 10 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
G | GENPACT LIMITED | $1,424,623,000 | +1.7% | 57,537,264 | 0.0% | 26.42% | -2.5% | |
MIK | MICHAELS COS INC | $1,182,168,000 | +9.5% | 52,798,929 | 0.0% | 21.92% | +4.9% | |
BFAM | BRIGHT HORIZONS FAM SOL IN D | $908,118,000 | +3.5% | 12,527,492 | 0.0% | 16.84% | -0.8% | |
Q | QUINTILES IMS HOLDINGS INC | $800,792,000 | +5.9% | 9,944,017 | 0.0% | 14.85% | +1.5% | |
ATTO | ATENTO S A | $573,339,000 | +19.6% | 62,660,015 | 0.0% | 10.63% | +14.6% | |
VRTV | Sell | VERITIV CORP | $221,903,000 | -32.1% | 4,283,840 | -29.6% | 4.12% | -35.0% |
ACHC | ACADIA HEALTHCARE COMPANY IN | $150,516,000 | +31.7% | 3,452,202 | 0.0% | 2.79% | +26.3% | |
FI | Buy | FRANKS INTL N V | $89,918,000 | -14.1% | 8,506,930 | +0.0% | 1.67% | -17.7% |
ITGR | INTEGER HLDGS CORP | $39,486,000 | +36.5% | 982,235 | 0.0% | 0.73% | +30.7% | |
NVTRQ | NUVECTRA CORP | $2,236,000 | +35.8% | 327,411 | 0.0% | 0.04% | +28.1% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bain Capital Partners X, L.P. #1
- Bain Capital Fund X, L.P. #2
- Bain Capital Integral Investors 2008, L.P. #3
- Bain Capital Partners Europe III, L.P. #4
- Bain Capital Europe Fund III, L.P. #5
- Bain Capital Partners VII, L.P. #6
- Bain Capital Fund VII, L.P. #7
- Bain Capital VII Coinvestment Fund, L.P. #8
- UWW Holdings, LLC #9
- Bain Capital Integral Investors 2006, LLC #10
- Bain Capital Partners Asia II, L.P. #11
- Glory Investments A Limited #12
- Glory Investments B Limited #13
- Atalaya Luxco S.a.r.l. #14
- Atalaya Luxco Topco S.C.A. #15
- Atalaya PIKco S.a.r.l. #16
- Atalaya Luxco PIKco SCA #17
- Bain Capital Partners VIII, L.P. #18
- Bain Capital Fund VIII, L.P. #19
- Bain Capital Fund VIII, LLC #20
- BC Brightness SPV GP, LLC #21
- BC Brightness SPV, LP #22
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICHAELS COS INC | 27 | Q1 2021 | 45.7% |
GENPACT LIMITED | 26 | Q3 2019 | 43.3% |
VERITIV CORP | 26 | Q4 2020 | 7.1% |
SURGERY PARTNERS INC | 25 | Q3 2023 | 54.6% |
ATENTO S A | 25 | Q4 2020 | 14.1% |
BRIGHT HORIZONS FAM SOL IN D | 19 | Q4 2017 | 18.4% |
QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 15.1% |
IQVIA HLDGS INC | 16 | Q3 2021 | 17.2% |
VONAGE HLDGS CORP | 13 | Q2 2016 | 0.0% |
CEREVEL THERAPEUTICS HLDNG, INC. | 12 | Q3 2023 | 42.1% |
View BAIN CAPITAL INVESTORS LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
4 | 2023-12-21 |
13F-HR | 2023-11-14 |
4 | 2023-10-18 |
13F-HR | 2023-08-14 |
4 | 2023-07-06 |
4 | 2023-06-12 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
4 | 2022-11-23 |
View BAIN CAPITAL INVESTORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.